IQVIA Holdings Inc. (IQV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of IQVIA Holdings Inc. (IQV)
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Key Insights
Critical company metrics and information
Share Price
$202.89Market Cap
$36.83 BillionTotal Outstanding Shares
181.50 Million SharesTotal Employees
88,000Dividend
No dividendIPO Date
May 9, 2013SIC Description
Services-commercial Physical & Biological ResearchHomepage
https://www.iqvia.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Operating Activities, Continuing | $721.00 Million |
Exchange Gains/Losses | $42.00 Million |
Net Cash Flow | $27.00 Million |
Net Cash Flow From Investing Activities, Continuing | $-599.00 Million |
Net Cash Flow, Continuing | $-15.00 Million |
Net Cash Flow From Operating Activities | $721.00 Million |
Net Cash Flow From Financing Activities | $-137.00 Million |
Net Cash Flow From Financing Activities, Continuing | $-137.00 Million |
Net Cash Flow From Investing Activities | $-599.00 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Income/Loss From Equity Method Investments | $1.00 Million |
Benefits Costs and Expenses | $3.55 Billion |
Cost Of Revenue | $2.98 Billion |
Gross Profit | $915.00 Million |
Costs And Expenses | $3.55 Billion |
Net Income/Loss | $285.00 Million |
Basic Average Shares | $182.10 Million |
Income Tax Expense/Benefit | $65.00 Million |
Diluted Average Shares | $184.20 Million |
Income/Loss From Continuing Operations After Tax | $284.00 Million |
Interest Expense, Operating | $170.00 Million |
Operating Income/Loss | $550.00 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Basic Earnings Per Share | $1.57 |
Revenues | $3.90 Billion |
Income Tax Expense/Benefit, Deferred | $-34.00 Million |
Diluted Earnings Per Share | $1.55 |
Income/Loss Before Equity Method Investments | $349.00 Million |
Net Income/Loss Available To Common Stockholders, Basic | $285.00 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Operating Expenses | $365.00 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Net Income/Loss Attributable To Parent | $285.00 Million |
Selling, General, and Administrative Expenses | $522.00 Million |
Income/Loss From Continuing Operations Before Tax | $349.00 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Accounts Receivable | $3.20 Billion |
Equity Attributable To Parent | $6.97 Billion |
Liabilities | $20.21 Billion |
Current Assets | $5.63 Billion |
Intangible Assets | $4.73 Billion |
Assets | $27.18 Billion |
Noncurrent Assets | $21.55 Billion |
Noncurrent Liabilities | $13.22 Billion |
Other Current Assets | $2.24 Billion |
Other Non-current Assets | $16.30 Billion |
Current Liabilities | $6.99 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Equity | $6.97 Billion |
Liabilities And Equity | $27.18 Billion |
Prepaid Expenses | $195.00 Million |
Fixed Assets | $513.00 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Related Companies
View additional S&P 500 companies similar to IQVIA Holdings Inc. (IQV)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.